Cargando…
From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment
Multiple sclerosis (MS) is a chronic, autoimmune, demyelinating disease of the central nervous system (CNS). Microbes, including bacteria and certain viruses, particularly Epstein–Barr virus (EBV), have been linked to the pathogenesis of MS. While there is currently no cure for MS, antibiotics and a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668955/ https://www.ncbi.nlm.nih.gov/pubmed/38002068 http://dx.doi.org/10.3390/biomedicines11113069 |